Skip to main content

Main navigation

  • About
    • Members
    • Our Team
    • Annual Report
    • Rutgers-NPC Health Policy & Communications Fellowship
    • NPC Summer Scholars
    • Contact Us
  • Topics
    • Health Spending
      • IRA & Medicare Drug Price Negotiation
      • 340B Drug Pricing Program
      • Understanding Health Spending
      • Low-Value Care
      • Health Spend Management
    • Value Assessment
      • Value Assessment Frameworks
      • Value Assessment Methods
      • Elements of Value
    • Alternative Payment Models
      • Value-Based Contracts
      • Regulatory Barriers & Challenges
      • Paying for Cures
      • Accountable Care Organizations
      • Bundled Payments
      • Health Care Quality Measures
      • Clinical Pathways
    • Patient-Centered Formulary & Benefit Design
      • High-Deductible Health Plans
      • Value-Based Insurance Design
      • Utilization Management & Step Therapy
      • Formulary Development
      • Patient Cost Sharing
      • Individual Treatment Effects & Personalized Access
    • Evidence for Decision Making
      • Real-World Data
      • Real-World Evidence
      • Good Practices for Evidence
    • Biopharma Innovation
      • Impact on Outcomes & Spending
  • Resources
    • Research
    • Fact Sheets
    • Policy & Evidence Briefs
    • Letters & Comments
    • E.V.I.dently Today Blog
    • Newsletters
    • Events
    • CER Daily Newsfeed®
    • Press Room
      • NPC in the News
      • NPC Press Releases
    • Videos and Graphics
    • Stakeholder Resources
      • For Employers
      • For Patient Organizations
      • Going Below The Surface
  • Get Involved
    • Become a Member
    • Submit a Research Proposal
    • Start a Career
  • Members Only
    • Value of Membership
      • Strategic Plan
      • Research Pipeline
    • Member Resources
      • Weekly Leadership Memo
      • Government Price-Setting & IRA Implementation Member Resources
      • Value Assessment & ICER-Related Member Resources
      • Health Spending & Drug Pricing Member Resources
      • Other Policy-Relevant Member Resources
    • Member Events
      • Leadership Forums
    • Board of Directors
    • Committees & Workgroups
      • Audit & Budget
      • Board-Level Research Committee
      • Executive Committee
      • Strategic Advisory Group
      • Corresponding Officers
      • Research Work Group
      • Employer Work Group
      • Policy & Communications Work Group
    • Logout
National Pharmaceutical Council

Offscreen menu

User account menu

  • Member Resources

Geographic Disparities in Influenza Vaccination Among Medicaid Beneficiaries: A National Analysis

  • Read more about Geographic Disparities in Influenza Vaccination Among Medicaid Beneficiaries: A National Analysis

Prescription Drug Utilization and Spending by Race, Ethnicity, Payer, Health Condition, and US State

  • Read more about Prescription Drug Utilization and Spending by Race, Ethnicity, Payer, Health Condition, and US State

New Study Reveals Significant Racial and Ethnic Disparities in Prescription Drug Utilization and Spending Across the United States

  • Read more about New Study Reveals Significant Racial and Ethnic Disparities in Prescription Drug Utilization and Spending Across the United States

How To Effectively Integrate Patient Perspectives Into Payer Coverage Decisions

  • Read more about How To Effectively Integrate Patient Perspectives Into Payer Coverage Decisions

The Time Is Now: Addressing Health Inequities in the Workforce

  • Read more about The Time Is Now: Addressing Health Inequities in the Workforce

Improving Access to Gene Therapies: A Holistic View of Current Challenges and Future Policy Solutions in the United States

  • Read more about Improving Access to Gene Therapies: A Holistic View of Current Challenges and Future Policy Solutions in the United States

NPC Provides Comments to CMS on the Notice of Benefit and Payment Parameters (NBPP) for Calendar Year 2026

  • Read more about NPC Provides Comments to CMS on the Notice of Benefit and Payment Parameters (NBPP) for Calendar Year 2026

NPC Submits Comments to CMS on Proposed Rule on CY 2025 Payment Policies and More

  • Read more about NPC Submits Comments to CMS on Proposed Rule on CY 2025 Payment Policies and More

NPC Submits Comments Regarding the Medicare Hospital Outpatient Prospective Payment System

  • Read more about NPC Submits Comments Regarding the Medicare Hospital Outpatient Prospective Payment System

Specialty drug use for autoimmune conditions varies by race and wage among employees with employer-sponsored health insurance

  • Read more about Specialty drug use for autoimmune conditions varies by race and wage among employees with employer-sponsored health insurance

Pagination

  • Page 1
  • Next page
Subscribe to Individual Treatment Effects & Personalized Access

Let's stay in touch.

Subscribe to our newsletter.
© 2026 NPC. All rights reserved.

Footer Menu

  • Accessibility
  • Privacy Policy
  • Terms of Use
  • Contact Us

Footer Social Links Menu

  • Twitter image/svg+xml
  • Linkedin
  • Youtube